“Turn on, tune in, get better: psychedelic drugs hold medical promise”
Scientific American (2014)
Amanda Feilding and the Beckley Foundation are delighted to invite you to Psychedelic Science 2017, which we are proud to be co-hosting with MAPS. The six-day gathering will bring together scientists, doctors, therapists, policy-makers and artists from across the psychedelic community to share their latest discoveries, achievements and creations.
Since we last came together for Psychedelic Science 2013, we have seen the world’s first images of the human brain on LSD, witnessed ayahuasca alkaloids stimulate the birth of new neurons and significantly strengthened the case for the therapeutic potential of psilocybin and MDMA.
Each year brings forth more firsts for psychedelic science from leading researchers around the world. As evidence mounts for the therapeutic value of these substances, we are witnessing a dramatic shift in scientific and public opinion. An increasing number of psychiatrists are supporting the new wave of research, and for the first time since the 50s and 60s, psychedelic treatments for common psychiatric conditions are being re-considered.
Psychedelic Science 2017 will celebrate the incredible advances being made in this exciting field of research and explore the opportunities and challenges that lie ahead for psychedelic pharmacology, psychedelic-assisted psychotherapy, plant medicines, and spirituality.
With over 175 speakers, three full days of workshops, exhibitions, market stalls, poster sessions, and a sunset cruise on the San Francisco Bay, there is much to look forward to. So join us from April 19-24 in Oakland, California.
Tickets for Psychedelic Science 2017 are still on sale but are selling out fast!
Psilocybin for Depression
Type of publication